Holen Sie sich die Stockscreener-App
7.16
2.19%
-0.14
Handel nachbörslich:
7.16
Schlusskurs vom Vortag:
$7.30
Offen:
$7.38
24-Stunden-Volumen:
790.20K
Relative Volume:
1.97
Marktkapitalisierung:
$479.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-122.44M
KGV:
-3.1766
EPS:
-2.254
Netto-Cashflow:
$-103.79M
1W Leistung:
-17.74%
1M Leistung:
-26.99%
6M Leistung:
+25.04%
1J Leistung:
+33.46%
1-Tages-Spanne:
$6.94
$7.43
1-Wochen-Bereich:
$6.60
$8.39
52-Wochen-Spanne:
$2.65
$12.25
Engene Holdings Inc Stock (ENGN) Company Profile
Firmenname
Engene Holdings Inc
Sektor
Branche
Telefon
(514) 332-4888
Adresse
4868 RUE LEVY, SUITE 220, SAINT-LAURENT
Compare ENGN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENGN
Engene Holdings Inc
|
7.16 | 489.02M | 0 | -122.44M | -103.79M | -2.254 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Engene Holdings Inc Stock (ENGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Eingeleitet | Jefferies | Buy |
| 2025-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-02-18 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-14 | Herabstufung | UBS | Buy → Neutral |
| 2024-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-27 | Eingeleitet | Raymond James | Outperform |
| 2024-11-18 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-08-28 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-04-15 | Eingeleitet | Guggenheim | Buy |
| 2024-03-28 | Eingeleitet | UBS | Buy |
| 2024-03-08 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Engene Holdings Inc Aktie (ENGN) Neueste Nachrichten
Oppenheimer Issues Pessimistic Forecast for enGene (NASDAQ:ENGN) Stock Price - Defense World
AI Stocks: Will enGene Holdings Inc stock benefit from M A2026 Short Interest & Entry and Exit Point Strategies - baoquankhu1.vn
enGene Holdings: Key Catalysts Incoming For 2026 (NASDAQ:ENGN) - Seeking Alpha
HC Wainwright Has Optimistic Outlook of enGene Q2 Earnings - MarketBeat
Citizens reiterates Engene Holdings stock rating on BLA timeline - Investing.com
FY2030 Earnings Forecast for enGene Issued By HC Wainwright - Defense World
enGene (NASDAQ:ENGN) Price Target Lowered to $30.00 at Oppenheimer - MarketBeat
Pullback Watch: How does enGene Holdings Inc compare to its peers2026 Highlights & Weekly High Return Opportunities - baoquankhu1.vn
ENGN: Detalimogene offers promising efficacy and convenience for NMIBC, with pivotal data updates ahead - TradingView
HC Wainwright Has Positive Outlook of enGene FY2030 Earnings - MarketBeat
Earnings Recap: Why is enGene Holdings Inc Equity Warrant stock going up2026 Fundamental Recap & Smart Investment Allocation Insights - baoquankhu1.vn
enGene (NASDAQ:ENGN) Posts Earnings Results, Beats Estimates By $0.11 EPS - MarketBeat
ENGN: Detalimogene offers a unique, highly tolerable NMIBC therapy with pivotal data updates in 2024 - TradingView
Engene stock price target lowered to $27 by Guggenheim on estimates - Investing.com India
Raymond James Maintains Strong Buy on ENGN enGene Holdings Inc March 2026 - Meyka
enGene Holdings Inc. Q1 2026 Quarterly Report: Financial Statements, Management Discussion & Key Disclosures - Minichart
enGene Reports Q1 2026 Results, Advances Detalimogene for Bladder Cancer with Strong Cash Position and FDA Milestones 12 - Minichart
enGene Holdings Inc. Announces Sales Agreement with Leerink Partners LLC for At-the-Market Offering of Common Shares - Minichart
enGene (NASDAQ:ENGN) Shares Gap DownHere's Why - MarketBeat
Raymond James reiterates Engene Holdings stock Strong Buy rating By Investing.com - Investing.com South Africa
HC Wainwright Reiterates 'Buy' Rating for enGene Holdings (ENGN) - GuruFocus
enGene's (ENGN) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Raymond James reiterates Engene Holdings stock Strong Buy rating - Investing.com
enGene Reports First Quarter 2026 Financial Results and Provides Business Update - BioSpace
ENGN: Holistic protocol changes and regulatory support position the program for a strong commercial launch - TradingView
Junshi Biosciences Announces NMPA Acceptance of New Drug Applications for Toripalimab Injection (Subcutaneous) Across 12 Indications - GlobeNewswire Inc.
enGene Strengthens Balance Sheet as Bladder Cancer Gene Therapy Nears Key 2026 Milestones - TipRanks
Form 424B5 enGene Holdings Inc. - StreetInsider
Engene Holdings Enters Sales Agreement With Leerink Partners To Sell Common Shares - TradingView
enGene Holdings 10-Q: $0 Revenue, $0.44 Loss Per Share on $29.8M Net Loss - TradingView
Published on: 2026-03-08 16:12:47 - baoquankhu1.vn
MACD Signal: Will enGene Holdings Inc. stock hit new highs in YEAR2025 Investor Takeaways & Precise Trade Entry Recommendations - baoquankhu1.vn
enGene Holdings Inc. $ENGN Stock Position Lowered by Blue Owl Capital Holdings LP - MarketBeat
Aug Ideas: Will enGene Holdings Inc stock benefit from M APortfolio Update Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Is enGene Holdings Inc Equity Warrant stock a value trapJuly 2025 Update & Consistent Return Investment Signals - baoquankhu1.vn
Growth Report: What are the analyst revisions for enGene Holdings IncIs FACT stock a good investment in YEARQuarterly Earnings Summary & Verified Short-Term Trading Plans - baoquankhu1.vn
New Highs: Is enGene Holdings Inc Equity Warrants ROE strong enough2025 Buyback Activity & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Growth Value: Will enGene Holdings Inc stock hit new highs in YEARWeekly Risk Summary & Daily Profit Focused Stock Screening - baoquankhu1.vn
ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A Stock Quote, Share Price, News and Analysis - Longbridge
Trade Report: What analysts say about enGene Holdings Inc Equity Warrant stockWeekly Investment Recap & Fast Gain Stock Tips - baoquankhu1.vn
[EFFECT] enGene Holdings Inc. SEC Filing - Stock Titan
enGene (ENGN) Expected to Announce Earnings on Monday - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Down 31.5% in February - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
ENGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
enGene Maps BLA by End-2026, Targets 2027 Launch for Lead NMIBC Therapy at Oppenheimer Conference - Yahoo Finance
ENGN: Detalimogene shows 62% six-month CR rate in NMIBC, with launch targeted for 2027 - TradingView
Market Trends: How does enGene Holdings Inc compare to its peersJuly 2025 Retail & Safe Entry Point Identification - baoquankhu1.vn
Institution Moves: Is enGene Holdings Inc Equity Warrant stock a value trapJuly 2025 Levels & Consistent Growth Stock Picks - baoquankhu1.vn
CEO Moves: Is OCUL subject to activist investor interestMarket Volume Report & Safe Capital Growth Stock Tips - baoquankhu1.vn
ENGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Finanzdaten der Engene Holdings Inc-Aktie (ENGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.18%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):